Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study

References

• Multhoff G, Molls M, Radons J. Chronic inflammation in cancer development. Front Immunol. 2011;2:98.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. DOI:10.3322/caac.21660.
   Web of Science ®Google Scholar
• Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–687.
   PubMed Web of Science ®Google Scholar
• Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol. 2006;80:1197–1213.
   PubMed Web of Science ®Google Scholar
• Kudo M. Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice. Int J Clin Oncol. 2010;15:242–255.
   PubMed Web of Science ®Google Scholar
• Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene. 2006;25:3778–3786.
   PubMed Web of Science ®Google Scholar
• Chen H, Hu M, Xu F, et al. Understanding the inflammation-cancer transformation in the development of primary liver cancer. Hepatoma Res. 2018;4:29.
   Google Scholar
• Shao YY, Lin H, Li YS, et al. High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma. Jpn J Clin Oncol. 2017;47:949–953.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Yamashita T, Terashima T, et al. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study. BMC Cancer. 2017;17:870.
   PubMed Web of Science ®Google Scholar
• Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014;13:513–532.
   PubMed Web of Science ®Google Scholar
• Behari J. The Wnt/β-catenin signaling pathway in liver biology and disease. Expert Rev Gastroenterol Hepatol. 2010;4:745–756.
   PubMed Web of Science ®Google Scholar
• Russell JO, Monga SP. Wnt/β-Catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol. 2018;13:351–378.
   PubMed Web of Science ®Google Scholar
• Wang W, Smits R, Hao H, et al. Wnt/β-catenin signaling in liver cancers. Cancers (Basel). 2019;11:926.
   PubMed Web of Science ®Google Scholar
• He S, Tang S. WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yano H, Nakashima Y, et al. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol. 2002;17:994–1000.
   PubMed Web of Science ®Google Scholar
• Harada N, Oshima H, Katoh M, et al. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res. 2004;64:48–54.
   PubMed Web of Science ®Google Scholar
• Khalaf AM, Fuentes D, Morshid AI, et al. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma. 2018;5:61–73.
   PubMed Web of Science ®Google Scholar
• Kim E, Lisby A, Ma C, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909.
   PubMed Web of Science ®Google Scholar
• Sferrazza G, Corti M, Brusotti G, et al. Nature-derived compounds modulating Wnt/ β -catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases. Acta Pharm Sin B. 2020;10:1814–1834.
   PubMed Web of Science ®Google Scholar
• Serafino A, Sferrazza G, Colini Baldeschi A, et al. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Expert Opin Drug Discov. 2017;12:169–186.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Dougados M, Berdah L, et al. Diacerhein in the treatment of osteoarthritis of the Hip. Arthritis Rheum. 1994;37:529–536.
   PubMed Web of Science ®Google Scholar
• Gadotti VM, Martins DF, Pinto HF, et al. Diacerein decreases visceral pain through inhibition of glutamatergic neurotransmission and cytokine signaling in mice. Pharmacol Biochem Behav. 2012;102:549–554.
   PubMed Web of Science ®Google Scholar
• Spencer CM, Wilde MI. Diacerein. Drugs. 1997;53:98–108.
   PubMed Web of Science ®Google Scholar
• Malaguti C, Vilella CA, Vieira KP, et al. Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice. Int Immunopharmacol. 2008;8:782–791.
   PubMed Web of Science ®Google Scholar
• Bharti R, Dey G, Banerjee I, et al. Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Lett. 2017;388:292–302.
   PubMed Web of Science ®Google Scholar
• Bharti R, Dey G, Ojha PK, et al. Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer. Oncogene. 2016;35:3965–3975.
   PubMed Web of Science ®Google Scholar
• Tsai CY, Shiau AL, Chen SY, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum. 2007;56:544–554.
   PubMed Web of Science ®Google Scholar
• Leonavičienė L, Kirdaitė G, Bradūnaitė R, et al. Effect of gold nanoparticles in the treatment of established collagen arthritis in rats. Medicina (Kaunas). 2012;48:91–101.
   PubMed Web of Science ®Google Scholar
• Singh P, Pandit S, Mokkapati VRSS, et al. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci. 2018;19:1979.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Hitchins VM, Schrand AM, et al. Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicology. 2011;5:284–295.
   PubMed Web of Science ®Google Scholar
• Liao DJ, Blanck A, Eneroth P, et al. Diethylnitrosamine causes pituitary damage, disturbs hormone levels, and reduces sexual dimorphism of certain liver functions in the rat. Environ Health Perspect. 2001;109:943–947.
   PubMed Web of Science ®Google Scholar
• Caviglia JM, Schwabe RF. Expermintal Hepatocarcinogenesis. In: Pathobiology of human disease: a dynamic encyclopedia of disease mechanism. First edition. McManus LM, Mitchell RN, Editors. Amsterdam: Elsevier; Academic press, 2014. p.1866-1880.
   Google Scholar
• PN Magee, JM Barnes. The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Br J Cancer. 1956;10:114–122.
   PubMed Web of Science ®Google Scholar
• Iqbala M, Usanasea G, Oulmib K, et al. Preparation of gold nanoparticles and determination of their particles size via different methods. Mater Res Bull. 2016;79:97–104.
   Web of Science ®Google Scholar
• Abd El-Moneim OM, Abd El-Rahim AH, Hafiz NA. Evaluation of selenium nanoparticles and doxorubicin effect against hepatocellular carcinoma rat model cytogenetic toxicity and DNA damage. Toxicol Rep. 2018;5:771–776.
   PubMed Web of Science ®Google Scholar
• Paulino DSM, Mendes MCS, Camargo JA, et al. Diacerein treatment prevents colitis-associated cancer in mice. World J Clin Oncol. 2020;1:732–746.
   Google Scholar
• Gamble M. The hematoxylins and eosin. In: theory and practice of histological techniques 6th. In Bancroft J, Gamble M (editors). London: Churchill Livingstone. 2008. 121–134.
   Google Scholar
• Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699.
   PubMed Web of Science ®Google Scholar
• Jones M. Connective tissues and stain. In: Bancroft J, Gamble M, editors. Theory and practice of histological techniques. 6th ed. London: Churchill Livingstone; 2008. p. 135–160.
   Google Scholar
• Adebiyi OA, Adebiyi OO, Owira PM. Naringin reduces hyperglycemia-induced cardiac fibrosis by relieving oxidative stress. PLoS One. 2016 Mar 11;11(3):e0149890.
   PubMed Web of Science ®Google Scholar
• Buchlowalow BI, Bocker W. Immunohistochemistry. Basics and methods. Berlin Heidelberg: Springer Verlag; 2010. p. 48.
   Google Scholar
• Varghese F, Bukhari AB, Malhotra R, et al. An open-source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801.
   PubMed Web of Science ®Google Scholar
• Santos NP, Colaço AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: a review. Tumour Biol. 2017;39:1010428317695923.
   Google Scholar
• Archer MC. Mechanisms of action of N-nitroso compounds. Cancer Surv. 1989;8:241–250.
   PubMedGoogle Scholar
• Borbath I, Stärkel P. Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models. Acta Gastroenterol Belg. 2011;74:34–44.
   PubMed Web of Science ®Google Scholar
• Aravalli RN, Cressman EN, Steer CJ. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol. 2013;87:227–247.
   PubMed Web of Science ®Google Scholar
• Sadik NA, EL-Maraghy SA, Ismail MF. Diethylnitrosamine induced hepatocarcinogenesis in rats: possible chemoprevention by blueberries. Afr J Biochem Res. 2008;2:81–87.
   Google Scholar
• Al-Rejaie SS, Aleisa AM, Al-Yahya AA, et al. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol. 2009;15:1373–1380.
   PubMed Web of Science ®Google Scholar
• Mohammed FZ, Sultan AS, bas AM. Chemopreventive and therapeutic effect of capsaicin against diethylnitrosamine induced liver injury and hepatocellularcarcinoma in rats. Int J Biol Pharm Res. 2014;5:630–642.
   Google Scholar
• Wai KK, Liang Y, Zhou L, et al. The protective effects of Acanthus ilicifolius alkaloid A and its derivatives on pro- and anti-inflammatory cytokines in rats with hepatic fibrosis. Biotechnol Appl Biochem. 2015;62:537–546.
   PubMed Web of Science ®Google Scholar
• Ding YF, Wu ZH, Wei YJ, et al. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. J Cancer Res Clin Oncol. 2017;143:821–834.
   PubMed Web of Science ®Google Scholar
• Youssef MI, Maghraby H, Youssef EA, et al. Expression of Ki 67 in hepatocellular carcinoma induced by diethylnitrosamine in mice and its correlation with histopathological alterations. J Appl Pharm Sci. 2012;2:52–59.
   Google Scholar
• Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5(2):315–vi.
   PubMedGoogle Scholar
• Liu ZC, Ning F, Wang HF, et al. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65. Biochim Biophys Acta Gen Subj. 2017;1861:2568–2582.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu J, Hu X, et al. Prognostic and therapeutic values of tumor necrosis factor-alpha in hepatocellular carcinoma. Med Sci Monit. 2016;22:3694–3704.
   PubMed Web of Science ®Google Scholar
• Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64:1403–1415. Epub 2016 Feb 8. PMID: 268674.
   PubMed Web of Science ®Google Scholar
• Jing Y, Sun K, Liu W, et al. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. Cancer Lett. 2018;434:22–32.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121–124.
   PubMed Web of Science ®Google Scholar
• Johnson C, Han Y, Hughart N, et al. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1:58–70.
   PubMedGoogle Scholar
• Ge WS, Wang YJ, Wu JX, et al. L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep. 2014;9(6):2145–2151.
   PubMed Web of Science ®Google Scholar
• Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 2009;15:513–520.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Zeng T, Zhao XL, et al. Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats. Int J Biol Sci. 2012;8:363–374.
   PubMed Web of Science ®Google Scholar